110 related articles for article (PubMed ID: 30635166)
21. Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
Batra V; Makvandi M; Zuppa AF; Patel N; Elias J; Pryma DA; Maris JM
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27654664
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report).
Jindahra P; Vejjajiva A; Witoonpanich R; Sirisriro R; Sritara C; Pulkes T
J Med Assoc Thai; 2004 Oct; 87(10):1176-81. PubMed ID: 15560694
[TBL] [Abstract][Full Text] [Related]
23. Reduced lung uptake of iodine-123 metaiodobenzylguanidine in patients with myeloperoxidase antineutrophil cytoplasmic antibodies-positive vasculitis.
Yoshiike F; Koizumi T; Urushihata K; Hanaoka M; Kubo K
Respiration; 2006; 73(2):191-6. PubMed ID: 16141710
[TBL] [Abstract][Full Text] [Related]
24. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.
Simula S; Vanninen E; Viitanen L; Kareinen A; Lehto S; Pajunen P; Syvänne M; Kuikka J; Laakso M; Hartikainen J
J Nucl Med; 2002 Jan; 43(1):1-7. PubMed ID: 11801695
[TBL] [Abstract][Full Text] [Related]
25. Low cardiac 123I-MIBG uptake in late-onset familial amyloid polyneuropathy type I (TTR Met30).
Watanabe H; Misu K; Hirayama M; Hattori N; Yoshihara T; Doyu M; Sobue G
J Neurol; 2001 Jul; 248(7):627-9. PubMed ID: 11518010
[No Abstract] [Full Text] [Related]
26. No-carrier-added 123I-MIBG: an initial clinical study in patients with phaeochromocytoma.
Owens J; Bolster AA; Prosser JE; Cunningham S; Mairs RJ; Neilly JB; Reed NS; Hilditch TE
Nucl Med Commun; 2000 May; 21(5):437-40. PubMed ID: 10874700
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of 131I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBG.
Hoefnagel CA; Taal BG; Sivro F; Boot H; Valdes Olmos RA
Nucl Med Commun; 2000 Aug; 21(8):755-61. PubMed ID: 11039459
[TBL] [Abstract][Full Text] [Related]
28. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
Suga K; Ogasawara N; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
Eur J Nucl Med; 2000 May; 27(5):574-82. PubMed ID: 10853814
[TBL] [Abstract][Full Text] [Related]
29. Impairment of Iodine-123-Metaiodobenzylguanidine (
Higo K; Kubota K; Miyanaga S; Miyata M; Nakajo M; Jinguji M; Ohishi M
Int Heart J; 2018 Jan; 59(1):112-119. PubMed ID: 29332912
[TBL] [Abstract][Full Text] [Related]
30. Comparison of [123I]metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine level.
Kurata C; Shouda S; Mikami T; Wakabayashi Y; Nakano T; Sugiyama T; Tawarahara K; Sakata K
J Nucl Cardiol; 1997; 4(6):515-23. PubMed ID: 9456192
[TBL] [Abstract][Full Text] [Related]
31. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.
Braune S
Clin Auton Res; 2001 Dec; 11(6):351-5. PubMed ID: 11794715
[TBL] [Abstract][Full Text] [Related]
32. Uptake of
Bhanthumkomol P; Hijioka S; Mizuno N; Kuwahara T; Okuno N; Ito A; Tanaka T; Ishihara M; Hirayama Y; Onishi S; Niwa Y; Tajika M; Ito Y; Sasaki E; Inaba Y; Shimizu Y; Yatabe Y; Hara K
Clin J Gastroenterol; 2017 Aug; 10(4):364-370. PubMed ID: 28447327
[TBL] [Abstract][Full Text] [Related]
33. Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report.
Suzuki M; Hattori N; Orimo S; Fukumitsu N; Abo M; Kono Y; Sengoku R; Kurita A; Honda H; Inoue K
Mov Disord; 2005 May; 20(5):634-6. PubMed ID: 15704207
[TBL] [Abstract][Full Text] [Related]
34. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.
Quattrone A; Bagnato A; Annesi G; Novellino F; Morgante L; Savettieri G; Zappia M; Tarantino P; Candiano IC; Annesi F; Civitelli D; Rocca FE; D'Amelio M; Nicoletti G; Morelli M; Petrone A; Loizzo P; Condino F
Mov Disord; 2008 Jan; 23(1):21-7. PubMed ID: 17975812
[TBL] [Abstract][Full Text] [Related]
35. Is MIBG a substrate of P-glycoprotein?
Kiyono Y; Yamashita T; Doi H; Kuge Y; Katsura T; Inui K; Saji H
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):448-52. PubMed ID: 17096097
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Tc-99m EC and Tc-99m DTPA captopril scintigraphy to diagnose renal artery stenosis.
Uğur O; Serdengeçti M; Karaçalioğlu O; Peksoy I; Cekirge S; Aslan N; Ergün EL; Duranay M; Yurdakul M; Caner B; Bayhan H
Clin Nucl Med; 1999 Aug; 24(8):553-60. PubMed ID: 10439173
[TBL] [Abstract][Full Text] [Related]
37. Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report.
Nagayama H; Yamazaki M; Ueda M; Nishiyama Y; Hamamoto M; Katayama Y; Mori O
Mov Disord; 2008 May; 23(7):1055-1057. PubMed ID: 18398915
[No Abstract] [Full Text] [Related]
38. Elevated MIBG Activity at the Site of Erythema of Unknown Etiology.
Xie P; Monaghan R; Edwards K; Shao F; Zhuang H
Clin Nucl Med; 2017 Mar; 42(3):227-230. PubMed ID: 27997425
[TBL] [Abstract][Full Text] [Related]
39. Correlation between cardiac norepinephrine overflow during exercise and cardiac 123I-MIBG uptake in patients with chronic heart failure.
Sato M; Maehara K; Yaoita H; Otani H; Hirosaka A; Saito T; Onuki N; Komatsu N; Ishihata T; Maruyama Y
J Nucl Med; 2003 Oct; 44(10):1618-24. PubMed ID: 14530476
[TBL] [Abstract][Full Text] [Related]
40. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.
Cohen-Solal A; Esanu Y; Logeart D; Pessione F; Dubois C; Dreyfus G; Gourgon R; Merlet P
J Am Coll Cardiol; 1999 Mar; 33(3):759-66. PubMed ID: 10080478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
